Optiray (Ioversol)

Ioversol, the active ingredient in Optiray, is a iodinated contrast media presented as a solution for injection for intraarterial and intravenous use. It provides radiopaque contrast for diagnostic imaging procedures such as angiography, CT, urography and venography.

GNH USA supplies Optiray as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant documentation for global distribution. Customers receive dedicated technical support and reliable logistics tailored to each market's requirements.

Optiray (ioversol) is an iodinated contrast agent used in radiographic imaging procedures.

- Angiography: Enhances vascular visualization to aid diagnosis and interventional planning. - Computed tomography (CT) imaging: Improves tissue differentiation and lesion detection. - Urography: Highlights urinary tract structures for functional assessment. - Venography: Provides clear delineation of venous anatomy for evaluation.

Adverse reactions to Optiray may vary in frequency and severity.

Common Side Effects: - Warm sensation: Transient feeling of heat during injection. - Nausea: Mild gastrointestinal upset occurring shortly after administration. - Mild urticaria: Small, transient skin wheals without systemic involvement.

Serious or Rare Side Effects: - Anaphylaxis: Severe allergic reaction requiring immediate medical intervention. - Acute kidney injury: Deterioration of renal function, especially in patients with pre‑existing impairment. - Severe hypotension: Marked drop in blood pressure that may necessitate supportive care.

Before using Optiray, clinicians should consider several safety measures.

- Renal function assessment: Evaluate serum creatinine and eGFR to identify patients at risk of contrast‑induced nephropathy. - Iodine allergy screening: Verify history of hypersensitivity to iodine‑containing agents. - Dose minimisation: Use the lowest effective volume for the intended imaging study. - Vital sign monitoring: Observe blood pressure and heart rate during and after injection. - Thyroid disease caution: Avoid in patients with uncontrolled hyperthyroidism or thyroid storm. - Store at ambient temperature: Keep in original container, protect from moisture and direct light.

Optiray may interact with other agents that affect renal function or iodine handling.

Major Interactions (Avoid): - Concurrent iodinated contrast agents: Increases cumulative iodine load and risk of toxicity. - High‑dose iodine‑containing medications (e.g., amiodarone): May potentiate allergic reactions. - Radiopharmaceuticals relying on iodine uptake: Interferes with diagnostic accuracy.

Moderate Interactions (Monitor Closely): - Diuretics: Heighten risk of volume depletion and renal impairment. - Nephrotoxic antibiotics (e.g., aminoglycosides): May exacerbate kidney injury. - ACE inhibitors or ARBs: Potentially alter renal haemodynamics; monitor renal function.